back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-09-27 16:02 Tx date 2024-09-26 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
526,346 | |
| Filed 2023-10-02 21:36 Tx date 2023-09-28 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
426,346 | |
| Filed 2022-10-17 13:10 Tx date 2022-10-17 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
$-175,000
-100,000 vol $1.75 each |
0 | |
| Filed 2022-10-11 13:49 Tx date 2022-10-11 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$29,482
+25,000 vol $1.18 each |
325,000 | |
| Filed 2022-10-11 13:49 Tx date 2022-10-07 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,405
+4,700 vol $1.15 each |
300,000 | |
| Filed 2022-10-11 13:48 Tx date 2022-10-06 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,439
+5,600 vol $1.15 each |
295,300 | |
| Filed 2022-10-06 10:29 Tx date 2022-10-05 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,470
+17,800 vol $1.15 each |
289,700 | |
| Filed 2022-10-06 10:28 Tx date 2022-10-04 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$53,287
+46,900 vol $1.14 each |
271,900 | |
| Filed 2022-06-28 17:34 Tx date 2022-06-24 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$85,000
+58,621 vol $1.45 each |
326,346 | |
| Filed 2021-09-24 16:09 Tx date 2021-09-23 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$84,999
+27,070 vol $3.14 each |
267,725 | |
| Filed 2020-11-05 09:22 Tx date 2020-11-03 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$79,997
+15,655 vol $5.11 each |
240,655 | |
| Filed 2019-11-11 16:13 Tx date 2019-11-08 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$97,500
+75,000 vol $1.30 each |
225,000 | |
| Filed 2019-10-18 14:29 Tx date 2019-10-17 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$175,000
+100,000 vol $1.75 each |
100,000 | |
| Filed 2019-10-18 14:28 Tx date 2017-03-01 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-10-18 14:28 Tx date 2019-10-17 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$260,000
+200,000 vol $1.30 each |
225,000 | |
| Filed 2019-02-19 Tx date 2019-02-14 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$50,000
+50,000 vol $1.00 each |
150,000 | |
| Filed 2018-08-28 Tx date 2018-08-27 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,070
+3,700 vol $1.10 each |
25,000 | |
| Filed 2018-08-27 Tx date 2018-08-22 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,492
+19,900 vol $1.08 each |
19,900 | |
| Filed 2018-08-27 Tx date 2018-08-22 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,488
+1,400 vol $1.06 each |
21,300 | |
| Filed 2018-08-27 Tx date 2017-03-01 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-08-27 Tx date 2018-08-24 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,488
+1,400 vol $1.06 each |
||
| Filed 2018-07-13 Tx date 2018-07-11 |
$RSL
Pure Global Cannabis Inc. (formerly, Royal Sapphire Corp.) |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
350,000 | ||
| Filed 2017-11-15 Tx date 2017-11-10 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$144,000
+50,000 vol $2.88 each |
100,000 | |
| Filed 2017-11-15 Tx date 2017-03-01 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
50,000 |